Johns Hopkins Health Alert
Questionnaires Help Predict Inherited Colon Cancer Risk
After age 80, heredity is a major risk factor for colorectal cancer. Now scientists have a new tool to help them identify people at risk for genetically linked colon or endometrial cancer.
It’s not known exactly why colorectal cancer begins. Some people carry genes that make them unusually susceptible to certain cancers, and some people have genes that are specific for colorectal cancer. In fact, because colon cancer is relatively easy to identify in the precancerous stage, the genes involved in colon cancer were some of the first cancer-related genes to be identified and studied.
Now an article in the Journal of the American Medical Association (Volume 296, pages 1469 and 1479) reports that two independent research teams have developed questionnaires that may help identify the risk of a genetically linked hereditary colon or endometrial cancer.
Lynch syndrome, which represents 2 to 7 percent of all colorectal cancers, is due to a mutation on the genes MLH1, MSH2 or MSH6, which usually protect against cancer. It is also known as hereditary nonpolyposis colon cancer (HNPCC) and is connected with endometrial cancer. Genetic testing can confirm the syndrome, but it is expensive and may not be necessary. The written tests can screen for the possibility of Lynch syndrome based on patients’ answers to questions about family and personal health histories, say researchers at Johns Hopkins University, who developed one of the questionnaires. They validated the program, called MMRpro, by testing it on 279 patients’ family histories and then testing their genes.
A similar test based on histories of 1,914 patients was developed at the Brigham and Women’s Hospital in Boston. That program, called PREMM1,2, is a risk assessment for mutations on genes MLH1 and MSH2. The questionnaires are available free on the Internet, but researchers caution that they should be used with the advice of a physician or a genetic or cancer counselor.
Further references:
The original Johns Hopkins Press Release for MMRPod is here:
http://www.jhsph.edu/publichealthnews/press_releases/2006/chen_mmrpro.html
The model software is available to download at
http://astor.som.jhmi.edu/BayesMendel/mmrpro.html
The study authors warn that MMRpro results should be interpreted by physicians and cancer counselors.
The PREMM1,2 program is at the Dana-Farber Cancer Institute Website.
http://www.dfci.org/pat/cancer/gastrointestinal/crc-calculator/default.asp
There is an online 'quiz' but it is really intended for health professionals. There are special tables and so on at the bottom that should consulted as well before any 'results' can be determined.
So all means take the quiz, but discuss your results and concerns with your doctor.
Posted in Colon Cancer on January 8, 2008
Reviewed June 2011
Medical Disclaimer: This information is not intended to substitute for the advice of a physician. Click here for additional information: Johns Hopkins Health Alerts Disclaimer
Notify Me
Would you like us to inform you when we post new Colon Cancer Health Alerts?
Comments
Health Alerts registered users may post comments and share experiences here at their own discretion. We regret that questions on individual health concerns to the Johns Hopkins editors cannot be answered in this space.
The views expressed here do not constitute medical advice, and do not represent the position of Johns Hopkins Medicine or Remedy Health Media, LLC, which has no responsibility for any comments posted on this site.
Post a Comment
Already a subscriber?
Login
New to Johns Hopkins Health Alerts?
